The Daily Aus The world's largest study into ADHD meds
Apr 8, 2025
A groundbreaking study reveals that the benefits of ADHD medications significantly outweigh potential cardiovascular risks. It highlights the surge in ADHD diagnoses in Australia, with a focus on societal changes that have reduced stigma. The podcast dives into available treatment options, comparing stimulant and non-stimulant medications. It also addresses cardiovascular effects seen in nearly 23,000 participants, emphasizing the importance of monitoring patients' health, especially those with pre-existing conditions. Join the discussion on effective treatment and awareness.
AI Snips
Chapters
Transcript
Episode notes
ADHD as a Neurodevelopmental Condition
- ADHD is a neurodevelopmental condition affecting nervous system development.
- This leads to differences in brain function compared to neurotypical individuals.
ADHD Prevalence and Diagnosis Trends
- Around 1.3 million Australians (1 in 20) are estimated to have ADHD.
- Diagnoses are increasing, possibly due to reduced stigma and increased awareness.
Underdiagnosis of ADHD in Women
- Increased ADHD diagnoses may reflect a correction of past underdiagnosis, especially in women.
- Traditional diagnostic criteria were designed around young boys leading to this disparity.